- Home
- DNTH vs SPHR Comparison
DNTH vs SPHR Comparison
Compare DNTH & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | SPHR |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.8B |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DNTH | SPHR |
|---|---|---|
| Price | $89.30 | $128.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 13 |
| Target Price | $140.80 | ★ $179.92 |
| AVG Volume (30 Days) | ★ 660.0K | 402.8K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 113.03 |
| EPS | N/A | ★ N/A |
| Revenue | $2,036,000.00 | ★ $1,220,045,000.00 |
| Revenue This Year | N/A | $11.93 |
| Revenue Next Year | N/A | $0.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.81 |
| 52 Week Low | $32.28 | $57.01 |
| 52 Week High | $117.88 | $181.63 |
Technical Indicators
Market Signals| Indicator | DNTH | SPHR |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 34.64 |
| Support Level | $89.21 | $126.01 |
| Resistance Level | $91.04 | $148.98 |
| Average True Range (ATR) | 4.60 | 5.72 |
| MACD | -1.13 | -0.77 |
| Stochastic Oscillator | 23.83 | 2.21 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments: Sphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.